NEUROGENETICS
Scope & Guideline
Exploring the Genetic Blueprint of Neural Function
Introduction
Aims and Scopes
- Genetic Analysis of Neurological Disorders:
The journal places a strong emphasis on the genetic underpinnings of a wide variety of neurological disorders, including neurodevelopmental disorders, neurodegenerative diseases, and muscular dystrophies. Research often employs advanced genetic sequencing techniques such as whole-exome sequencing and next-generation sequencing. - Phenotype-Genotype Correlations:
A critical area of focus is the correlation between observed clinical phenotypes and underlying genotypes. This includes detailed studies that characterize the spectrum of symptoms associated with specific genetic variants, which is essential for diagnosis and treatment. - Epigenetics and Environmental Interactions:
Research in the journal also investigates the role of epigenetics and environmental factors in the manifestation of neurological disorders, highlighting how these factors can influence gene expression and disease progression. - Therapeutic Approaches and Clinical Implications:
The journal is dedicated to exploring novel therapeutic strategies, including genetic therapies and pharmacological interventions, to mitigate the impact of genetic disorders on neurological function. - International and Multi-Cohort Studies:
NEUROGENETICS frequently publishes studies that involve diverse patient cohorts across different geographical regions, enhancing the understanding of genetic diversity and its implications in neurological conditions.
Trending and Emerging
- Role of the Gut-Brain Axis in Neurological Disorders:
Emerging studies are increasingly exploring the gut-brain axis, including the impact of gut-derived metabolites like short-chain fatty acids on conditions such as Parkinson's disease, highlighting an interdisciplinary approach to neurogenetics. - 3D Genome Architecture in Neurodevelopmental Disorders:
Research focusing on the three-dimensional structure of the genome is gaining traction, as it provides insights into how genomic architecture can influence neurodevelopmental disorders, paving the way for new therapeutic avenues. - Integration of Genomics and Neuroimaging:
An emerging theme is the integration of genomic data with neuroimaging findings to better understand the structural and functional implications of genetic variants on brain health. - Longitudinal and Cohort Studies:
There is a trend towards conducting longitudinal studies that track genetic and phenotypic changes over time, which is crucial for understanding the progression of neurogenetic disorders. - Use of Computational Methods for Genetic Analysis:
The application of computational and bioinformatics methods to analyze genetic data is becoming more prevalent, facilitating the identification of novel variants and understanding their functional impacts.
Declining or Waning
- Traditional Genetic Testing Methods:
There is a noticeable decrease in studies relying solely on traditional genetic testing methods, such as karyotyping and basic mutation screening, as more advanced genomic techniques like whole-exome and whole-genome sequencing gain prominence. - Nutritional and Lifestyle Interventions:
Research focusing on the role of dietary and lifestyle interventions in managing neurological disorders has diminished, possibly overshadowed by more molecular and genetic-centric approaches. - General Neurological Conditions without Genetic Focus:
Papers addressing general neurological conditions without a specific genetic focus are becoming less common, as the journal increasingly prioritizes studies that directly link genetic findings to clinical outcomes. - Animal Models of Disease:
While animal models were once a prominent feature in studies related to neurogenetics, the emphasis appears to be shifting towards human cohort studies and genetic analyses, indicating a waning interest in preclinical models.
Similar Journals
HUMAN MOLECULAR GENETICS
Transforming insights into impactful genetic research.HUMAN MOLECULAR GENETICS, published by Oxford University Press, is a premier journal in the field of genetics, with an established reputation since its inception in 1992. With an impressive Q1 ranking in various categories, including Genetics, Clinical Genetics, and Molecular Biology, this journal engages a diverse readership by reporting significant advances in our understanding of the genetic basis of human health and disease. The journal has achieved notable rankings within Scopus, particularly in Clinical Genetics, making it a key resource for professionals and researchers aiming to stay at the forefront of genetic research. Although it operates under a traditional access model, it remains committed to disseminating high-quality research that informs clinical practice and enhances knowledge in the genetic field. The journal's impact factor signifies its crucial role in shaping contemporary genetic research and its application in medicine. As the field continues to evolve, HUMAN MOLECULAR GENETICS serves not only as an academic repository but also as a vital platform for innovation and discussion among students, researchers, and clinicians.
Global Medical Genetics
Empowering Knowledge in Global GeneticsGlobal Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.
GENETICS IN MEDICINE
Leading the Charge in Clinical GeneticsGENETICS IN MEDICINE, published by Elsevier Science Inc, stands as a premier journal in the realms of clinical genetics and medicine. With an impressive impact factor and ranked #3 out of 99 in the category of Genetics (clinical), alongside a 97th percentile ranking in the Scopus database, this journal is recognized for its outstanding contribution to the field. Established in 1998, it aims to disseminate innovative research and clinical advancements bridging genetics and medical practice, making it essential reading for researchers, healthcare professionals, and students alike. Although not an open-access journal, GENETICS IN MEDICINE provides valuable insights into genetics that drive the future of personalized medicine and patient care. With a commitment to excellence, the journal continuously explores the evolving landscape of genetic research to foster the understanding and application of genetic principles in medical contexts.
Human Genome Variation
Bridging Research and Clinical ApplicationsHuman Genome Variation, published by SpringerNature, is an esteemed open access journal dedicated to the field of genetic research and exploration. Since its inception in 2014, the journal has been at the forefront of advancing our understanding of human genome diversity and its implications in health and disease. With an E-ISSN of 2054-345X, it features a diverse array of studies that encompass biochemistry, genetics, and molecular biology, making it an invaluable resource for researchers and professionals alike. The journal holds a Q3 ranking in both biochemistry and genetics, and a Q4 ranking in molecular biology, highlighting its growing influence within these disciplines. As the landscape of genomics continues to evolve, Human Genome Variation serves as a platform for the dissemination of high-quality research, fostering collaboration and innovation within the scientific community. Researchers and academics are invited to contribute to this pivotal journal, which not only provides open access to its content since 2014 but also aims to bridge the gap between basic research and clinical applications in genetics.
JOURNAL OF MEDICAL GENETICS
Elevating Understanding of Genetic Disorders Through Rigorous Research.JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Pioneering Studies for Tomorrow's Neurological ChallengesJOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, published by Oxford University Press Inc, stands as a pivotal resource for advancing research and knowledge in the domains of neuropathology and experimental neurology. Established in 1942, this esteemed journal has expanded its influence, as evidenced by its Q1 rankings in both Neurology (clinical) and Pathology and Forensic Medicine, along with its strong placement in Cellular and Molecular Neuroscience. With an emphasis on innovative research and clinical practices, it caters to a diverse audience, including researchers and clinicians dedicated to understanding neurological disorders through a multidisciplinary lens. While not open access, this journal provides access to cutting-edge studies that are pivotal in shaping the future of medical science and pathology. Researchers benefit from its rigorous peer-review process, ensuring the publication of high-caliber work that meets the evolving demands of the field.
NEUROPEDIATRICS
Empowering clinicians with cutting-edge insights in pediatric care.NEUROPEDIATRICS is a prominent academic journal published by GEORG THIEME VERLAG KG, dedicated to advancing the understanding and treatment of neurological disorders in children. Established in 1980, this journal has consistently provided a platform for innovative research and clinical practice in the fields of pediatrics and neurology, culminating in its recognition across various rankings; it holds a Q2 rating in Pediatrics, Perinatology and Child Health, and Q3 in both Medicine (miscellaneous) and Neurology (clinical) as of 2023. While NEUROPEDIATRICS is not an open access journal, it remains a crucial resource for researchers, clinicians, and students who seek cutting-edge insights and evidence-based practices in the management of pediatric neurological issues. As a result, NEUROPEDIATRICS plays an indispensable role in shaping future research directions and improving health outcomes in this vital field.
Neurology-Genetics
Connecting Discoveries in Neurology and Genetics for a Healthier Future.Neurology-Genetics, an esteemed journal published by LIPPINCOTT WILLIAMS & WILKINS, is at the forefront of advancing the fields of neurology and genetics. With a dedicated Open Access model since 2015, this journal ensures that cutting-edge research is readily available to researchers, professionals, and students worldwide. Operating from the United States, Neurology-Genetics has established a reputable position within the scientific community, as reflected by its impressive rankings in Scopus; it holds a Q1 ranking in clinical neurology and a Q2 ranking in clinical genetics, showcasing its dual commitment to these intertwined fields. With an impact factor that continues to grow alongside its reach, the journal encourages the dissemination of novel findings, innovative methodologies, and critical reviews that contribute to the understanding and treatment of neurological and genetic disorders. Researchers and practitioners are invited to engage with the latest discoveries and discussions, making Neurology-Genetics an essential resource for anyone involved in these dynamic areas of study.
Molecular Syndromology
Bridging Molecular Insights with Clinical ApplicationsMolecular Syndromology is a premier journal focused on the intricate connections between molecular genetics and syndromology, fostering discussions that advance our understanding of genetic disorders and their clinical implications. Published by KARGER, a distinguished name in medical and scientific publishing, this journal serves as a valuable platform for researchers, clinicians, and students in the field of genetics. With its ISSN 1661-8769 and E-ISSN 1661-8777, the journal has gained recognition in its category, currently positioned in the Q4 quartile for both genetic and clinical genetics disciplines according to the latest metrics. Despite being indexed lower in Scopus rankings, it addresses crucial gaps in research and offers open access options that enhance visibility and dissemination of knowledge. As it continues to converge from 2010 to 2024, Molecular Syndromology aims to bridge the gap between molecular research and its clinical applications, making a significant impact in the evolving landscape of genetic medicine.
Genetic Testing and Molecular Biomarkers
Illuminating Pathways in Genetic Testing and Biomarker Discovery.Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.